company background image

Utah Medical Products NasdaqGS:UTMD Stock Report

Last Price


Market Cap







26 Jun, 2022


Company Financials
UTMD fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance5/6
Financial Health6/6

UTMD Stock Overview

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry.

Utah Medical Products Competitors













Price History & Performance

Summary of all time highs, changes and price drops for Utah Medical Products
Historical stock prices
Current Share PriceUS$86.97
52 Week HighUS$133.87
52 Week LowUS$80.31
1 Month Change4.48%
3 Month Change-3.91%
1 Year Change-0.034%
3 Year Change-9.12%
5 Year Change20.12%
Change since IPO1,204.55%

Recent News & Updates

May 14
Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Utah Medical Products, Inc. ( NASDAQ:UTMD ) has announced that it will pay a dividend of US$0.29 per share on the 6th...

Shareholder Returns

UTMDUS Medical EquipmentUS Market

Return vs Industry: UTMD exceeded the US Medical Equipment industry which returned -23.7% over the past year.

Return vs Market: UTMD exceeded the US Market which returned -18.5% over the past year.

Price Volatility

Is UTMD's price volatile compared to industry and market?
UTMD volatility
UTMD Average Weekly Movement2.6%
Medical Equipment Industry Average Movement10.5%
Market Average Movement8.0%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market3.1%

Stable Share Price: UTMD is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: UTMD's weekly volatility (3%) has been stable over the past year.

About the Company

1978195Kevin Cornwell

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies.

Utah Medical Products Fundamentals Summary

How do Utah Medical Products's earnings and revenue compare to its market cap?
UTMD fundamental statistics
Market CapUS$317.00m
Earnings (TTM)US$15.30m
Revenue (TTM)US$50.41m


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
UTMD income statement (TTM)
Cost of RevenueUS$18.91m
Gross ProfitUS$31.50m
Other ExpensesUS$16.21m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date


Earnings per share (EPS)4.20
Gross Margin62.49%
Net Profit Margin30.35%
Debt/Equity Ratio0%

How did UTMD perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
We’ve recently updated our valuation analysis.


Is UTMD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 4/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • PEG Ratio

Key Valuation Metric

Which metric is best to use when looking at relative valuation for UTMD?

Other financial metrics that can be useful for relative valuation.

UTMD key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue5x
Enterprise Value/EBITDA9.4x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does UTMD's PE Ratio compare to its peers?

UTMD PE Ratio vs Peers
The above table shows the PE ratio for UTMD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average36.6x

Price-To-Earnings vs Peers: UTMD is good value based on its Price-To-Earnings Ratio (20.7x) compared to the peer average (36.6x).

Price to Earnings Ratio vs Industry

How does UTMD's PE Ratio compare vs other companies in the U.S. Medical Equipment Industry?

Price-To-Earnings vs Industry: UTMD is good value based on its Price-To-Earnings Ratio (20.7x) compared to the US Medical Equipment industry average (34.8x)

Price to Earnings Ratio vs Fair Ratio

What is UTMD's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

UTMD PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio20.7x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate UTMD's Price-To-Earnings Fair Ratio for valuation analysis.

Share Price vs Fair Value

What is the Fair Price of UTMD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: UTMD ($86.97) is trading below our estimate of fair value ($149.66)

Significantly Below Fair Value: UTMD is trading below fair value by more than 20%.

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate UTMD's PEG Ratio to determine if it is good value.

Discover undervalued companies

Future Growth

How is Utah Medical Products forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score


Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Utah Medical Products has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Discover growth companies

  • Examine whether Utah Medical Products is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.

Past Performance

How has Utah Medical Products performed over the past 5 years?

Past Performance Score


Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: UTMD has high quality earnings.

Growing Profit Margin: UTMD's current net profit margins (30.3%) are higher than last year (25.3%).

Past Earnings Growth Analysis

Earnings Trend: UTMD's earnings have grown by 2.5% per year over the past 5 years.

Accelerating Growth: UTMD's earnings growth over the past year (43.2%) exceeds its 5-year average (2.5% per year).

Earnings vs Industry: UTMD earnings growth over the past year (43.2%) exceeded the Medical Equipment industry 12.9%.

Return on Equity

High ROE: UTMD's Return on Equity (14%) is considered low.

Discover strong past performing companies

Financial Health

How is Utah Medical Products's financial position?

Financial Health Score


Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: UTMD's short term assets ($79.5M) exceed its short term liabilities ($6.1M).

Long Term Liabilities: UTMD's short term assets ($79.5M) exceed its long term liabilities ($4.5M).

Debt to Equity History and Analysis

Debt Level: UTMD is debt free.

Reducing Debt: UTMD has not had any debt for past 5 years.

Debt Coverage: UTMD has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: UTMD has no debt, therefore coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies


What is Utah Medical Products's current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 3/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage


Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: UTMD's dividend (1.33%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.57%).

High Dividend: UTMD's dividend (1.33%) is low compared to the top 25% of dividend payers in the US market (4.24%).

Stability and Growth of Payments

Stable Dividend: UTMD's dividends per share have been stable in the past 10 years.

Growing Dividend: UTMD's dividend payments have increased over the past 10 years.

Earnings Payout to Shareholders

Earnings Coverage: With its low payout ratio (20.5%), UTMD's dividend payments are well covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: With its low cash payout ratio (21.2%), UTMD's dividend payments are well covered by cash flows.

Discover strong dividend paying companies


How experienced are the management team and are they aligned to shareholders interests?


Average board tenure


Kevin Cornwell (74 yo)





Mr. Kevin L. Cornwell has been the Chairman of the Board at Utah Medical Products Inc. since 1996 and its President and Chief Executive Officer since December 1992. Mr. Cornwell has been Secretary of Utah...

CEO Compensation Analysis

Compensation vs Market: Kevin's total compensation ($USD494.21K) is below average for companies of similar size in the US market ($USD2.84M).

Compensation vs Earnings: Kevin's compensation has increased by more than 20% in the past year.

Board Members

Experienced Board: UTMD's board of directors are seasoned and experienced ( 25.4 years average tenure).


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: UTMD insiders have only sold shares in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

Utah Medical Products, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Utah Medical Products, Inc.
  • Ticker: UTMD
  • Exchange: NasdaqGS
  • Founded: 1978
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Implied Market Cap: US$317.005m
  • Shares outstanding: 3.64m
  • Website:

Number of Employees


  • Utah Medical Products, Inc.
  • 7043 South 300 West
  • Midvale
  • Utah
  • 84047-1048
  • United States


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/06/26 00:00
End of Day Share Price2022/06/24 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.